An API for Genome Apps
By The Daily Scan,
The Daily Scan
| 09. 20. 2012
23andMe is opening up its application programming interface so that third-party developers can create apps that will piggyback on customers' personal genome data.
The company, which announced the API launch at last week's Quantified Self conference, says that genome apps should be of great interest to "self-tracker” community. Conference attendees "immediately latched onto the potential of the Personal Genome API for the self-tracking movement. Integrating various sets of genetic traits into sleep trackers, for example, was a popular topic."
Mike Polcari, director of engineering at 23andMe, tells Daily Scan sister publication BioInform that the company is taking privacy seriously. Interested developers will have to apply online in order to ensure that they are "real and identifiable "and that they "are being thoughtful about which pieces of the genome they are accessing," Polcari says.
In addition, individual-level data won't be personally identifiable to developers, and 23andMe customers will be able to decide whether they want their data accessible to an app.
Wired UK speculates that there may be a benefit for 23andMe benefactor Google, noting that "with the attitudes toward personal...
Related Articles
By David Jensen, California Stem Cell Report | 02.10.2026
Touchy issues involving accusations that California’s $12 billion gene and stem cell research agency is pushing aside “good science” in favor of new priorities and preferences will be aired again in late March at a public meeting in Sacramento.
The...
By Lauren Hammer Breslow and Vanessa Smith, Bill of Health | 01.28.2026
On Jan. 24, 2026, the New York Times reported that DNA sequences contributed by children and families to support a federal effort to understand adolescent brain development were later co-opted by other researchers and used to publish “race science”...
By Arthur Lazarus, MedPage Today | 01.23.2026
A growing body of contemporary research and reporting exposes how old ideas can find new life when repurposed within modern systems of medicine, technology, and public policy. Over the last decade, several trends have converged:
- The rise of polygenic scoring...
By Stephanie Pappas, LiveScience | 01.15.2026
Genetic variants believed to cause blindness in nearly everyone who carries them actually lead to vision loss less than 30% of the time, new research finds.
The study challenges the concept of Mendelian diseases, or diseases and disorders attributed to...